We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.3B
AUM Growth
+$479M
Cap. Flow
-$13.7M
Cap. Flow %
-0.32%
Top 10 Hldgs %
47.06%
Holding
186
New
16
Increased
26
Reduced
83
Closed
3

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$5.46M
2
FERG icon
Ferguson
FERG
+$3.54M
3
OWL icon
Blue Owl Capital
OWL
+$3.32M
4
FTRE icon
Fortrea Holdings
FTRE
+$3M
5
SCHW
Charles Schwab
SCHW
+$2.76M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$7.68M
2
WMS icon
Advanced Drainage Systems
WMS
+$7.19M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.95M
4
MSFT icon
Microsoft
MSFT
+$5.14M
5
MA icon
Mastercard
MA
+$3.07M

Sector Composition

Rank Sector Weight
1 Financials 40.69%
2 Healthcare 13.57%
3 Technology 12.87%
4 Communication Services 7.57%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OTIS icon
126
Otis Worldwide
OTIS
$27.9B
$407K 0.01%
4,547
– –
LUMN icon
127
Lumen
LUMN
$6.43B
$389K 0.01%
212,323
– –
SCHV
128
Schwab US Large-Cap Value ETF
SCHV
$15.6B
$387K 0.01%
16,569
+117
+0.7% +$2.56K
TOST icon
129
Toast
TOST
$18.9B
$382K 0.01%
20,920
+5,000
+31% +$82K
DIS icon
130
Walt Disney
DIS
$171B
$373K 0.01%
4,132
-25
-0.6% -$2.2K
CL icon
131
Colgate-Palmolive
CL
$74.8B
$365K 0.01%
+4,576
New +$344K
EOG icon
132
EOG Resources
EOG
$77.7B
$361K 0.01%
2,985
-8
-0.3% -$996
BMY icon
133
Bristol-Myers Squibb
BMY
$129B
$349K 0.01%
6,797
-160
-2% -$8.4K
BSX icon
134
Boston Scientific
BSX
$68.4B
$347K 0.01%
6,000
– –
SRE icon
135
Sempra
SRE
$58.1B
$319K 0.01%
+4,266
New +$305K
TSM icon
136
TSMC
TSM
$1.94T
$318K 0.01%
+3,053
New +$291K
SDY icon
137
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$310K 0.01%
2,483
– –
PNC icon
138
PNC Financial Services
PNC
$99.1B
$310K 0.01%
2,000
– –
ALL icon
139
Allstate
ALL
$70.6B
$299K 0.01%
2,136
– –
BB icon
140
BlackBerry
BB
$4.58B
$297K 0.01%
84,000
-6,000
-7% -$22.5K
NVDA icon
141
NVIDIA
NVDA
$4.6T
$297K 0.01%
6,000
– –
DFS
142
DELISTED
Discover Financial Services
DFS
$285K 0.01%
2,540
– –
KMI icon
143
Kinder Morgan
KMI
$70.9B
$282K 0.01%
15,992
-5,700
-26% -$97.2K
VLTO icon
144
Veralto
VLTO
$24.3B
$281K 0.01%
+3,421
New +$255K
SO icon
145
Southern Company
SO
$108B
$273K 0.01%
3,900
– –
ITW icon
146
Illinois Tool Works
ITW
$84.1B
$261K 0.01%
998
-200
-17% -$47.9K
VB icon
147
Vanguard Small-Cap ETF
VB
$78.9B
$250K 0.01%
1,170
– –
GEHC icon
148
GE HealthCare
GEHC
$32.7B
$250K 0.01%
3,227
– –
AMP icon
149
Ameriprise Financial
AMP
$47.8B
$240K 0.01%
632
– –
MO icon
150
Altria Group
MO
$125B
$239K 0.01%
5,928
-175
-3% -$7.24K
3 4 5
6
7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2023 Portfolio in Review

As of Q4 2023, Beck Mack & Oliver held 186 positions worth $4.3B, up 13% from $3.82B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver's Q4 2023 filing shows 16 new, 26 increased, 83 reduced and 3 closed positions. Its largest new stake was CVS Health: 21,339 shares worth $1.68M. The largest sale was Sherwin-Williams, an estimated $7.68M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q4 2023 buy was CVS Health: 21,339 shares worth $1.68M.
  • Beck Mack & Oliver added most to Rush Enterprises Class A in Q4 2023, an estimated $5.46M increase.
  • Beck Mack & Oliver's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $7.68M.
  • Beck Mack & Oliver fully exited General Mills in Q4 2023, selling an estimated $384K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $4.3B portfolio in Q4 2023.
  • Beck Mack & Oliver opened 16 new positions and closed 3 in Q4 2023.
  • Beck Mack & Oliver's portfolio value rose 13% quarter-over-quarter to $4.3B.

Based on Beck Mack & Oliver's 13F filing for Q4 2023, filed 14 Feb 2024.